Barclays
INBS icon

Barclays’s Intelligent Bio Solutions INBS Stock Holding History

Barclays’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$326 Buy
+142
New +$373 ﹤0.01% 5059

Other funds holding INBS

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Barclays's INBS Position: Q2 2026 in Review

Barclays opened a new position in Intelligent Bio Solutions (INBS) in Q2 2026: 142 shares worth $326. The stake represents ﹤0.01% of the portfolio and ranks #5059 among its holdings.

8 funds tracked by Wall St. Rank hold INBS as of Q2 2026.

  • Barclays held 142 shares of Intelligent Bio Solutions worth $326 as of Q2 2026.
  • Intelligent Bio Solutions was a new Barclays position in Q2 2026.
  • Intelligent Bio Solutions made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5059 holding.
  • 8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.